Fact CheckerSign in

NCT00119912Active, not recruiting

NORCCAP: Norwegian Colorectal Cancer Prevention Trial

Norwegian Colorectal Cancer Prevention Trial

Source: ClinicalTrials.gov · Last updated 14 Apr 2026

Brief summary (registry, in English)

The purpose of this study is to see if screening with flexible sigmoidoscopy (a flexible viewing tube) may reduce large bowel cancer and cancer deaths. The researchers also want to see if the addition of screening for occult blood in stools may contribute further to this aim. Additionally, the researchers also want to see to which extent (and in which direction) the study may influence overall endoscopic activity in the general population in the screening area and in areas where controlled screening is not established.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
100000 (actual)
First submitted
6 Jul 2005
Start date
1 Jan 1999
Primary completion date
Dec 2036
Lead sponsor
Norwegian Institute of Public Health
NCT number
NCT00119912

What you commit to

  • Study type: Interventional
  • Participants enrolled: 100000
  • From 1 Jan 1999 to the primary completion date, Dec 2036
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with previous open colorectal surgery (resections, enterostomies)

Other illness

  • On-going cytotoxic treatment or radiotherapy for malignant disease
  • Severe chronic cardiac or lung disease (NYHA III-IV)
  • Patients with heart valve replacement on life long anticoagulant therapy

Other

  • Individuals in need of long lasting attention and nursing services (somatic or psychosocial reasons, mental retardation)
  • A coronary event during the last 3 months if having lead to hospitalisation
  • Cerebrovascular accident during the last 3 months
  • Resident abroad

Who the study is looking for

  • Men and women
  • Living in Oslo or Telemark
  • Age 50-64 years

Age in the registry: 50 years to 64 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Institute of Population-based Cancer Research
Coordinator of this site? Confirm its status
OsloNorwayUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.